PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.87
ESG score 80-90% of CGTX's 66.89. Walter Schloss would scrutinize governance quality and regulatory exposure.
50.00
Environmental score below 80% of CGTX's 65.49. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
61.14
Social score 90-95% of CGTX's 64.94. Bill Ackman would demand clear social improvement catalysts.
68.48
Similar governance score to CGTX's 70.23. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.